Marjolein van Ballegooijen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Marjolein van Ballegooijen has a total of 137 co-authors. Here are the top co-authors by number of shared publications:
- Ernst J. Kuipers
Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands
11 shared publications - Ann G. Zauber
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center , New York, NY
8 shared publications J.D. Habbema
6 shared publications- Iris Lansdorp-Vogelaar
Department of Public Health Erasmus University Medical Center Rotterdam The Netherlands
5 shared publications Jacqueline C. Reijerink
5 shared publicationsLieke Hol
5 shared publications
Latest Publications
- 1 November 2015
- Published by Elsevier in Gastroenterology
- Vol. 149 (6) , 1425-1437
Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness
- 1 November 2015
- Published by Elsevier in Gastroenterology
- Vol. 149 (6) , 1425-1437
Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness
- 17 June 2014
- Published by Springer Nature in Cancer Causes & Control
- Vol. 25 (9) , 1141-1149
Effectiveness of two strategies to follow-up ASC-US and LSIL screening results in The Netherlands using repeat cytology with or without additional hrHPV testing: a retrospective cohort study
The purpose of the study was to assess the effectiveness of repeat cytology with and without additional high-risk human papilloma virus (hrHPV) testing after atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion (ASC-US/LSIL) screening results. In the Netherlands, ASC-US/LSIL is triaged by repeat cytology at 6 months or repeat cytology at 6 months with additional hrHPV testing. ASC-US/LSIL results from 13,734 screenees in 2008 were extracted from “Dutch Pathology Registry” including cytology, histology, and/or HPV follow-up results. Proportions of compliance, repeat cytology, referral, and detected cervical intraepithelial neoplasia (CIN) were assessed. With additional hrHPV testing, 46.8 % was send back to regular screening at 6 months, 28.6 % needed second repeat cytology, and 24.6 % was referred for colposcopy. Without additional hrHPV testing, this was 0.0, 76.1, and 23.9 %, respectively. With additional hrHPV testing, significantly higher proportions of persisting ASC-US/LSIL; compliance with repeat/referral advices; and histological detection of CIN0 (no CIN or cancer), CIN1, and CIN2 were found but equal proportions CIN3+. Additional hrHPV testing shortens follow-up without altering CIN3+ detection. Detection of CIN0, CIN1, and CIN2 was higher, presumably by hrHPV-driven biased cytology and detection bias. Restricting additional hrHPV testing to older women, reading cytology without knowledge of hrHPV status, and addition of more specific triage tests could further improve the effectiveness of additional hrHPV testing.
- 17 June 2014
- Published by Springer Nature in Cancer Causes & Control
- Vol. 25 (9) , 1141-1149
Effectiveness of two strategies to follow-up ASC-US and LSIL screening results in The Netherlands using repeat cytology with or without additional hrHPV testing: a retrospective cohort study
The purpose of the study was to assess the effectiveness of repeat cytology with and without additional high-risk human papilloma virus (hrHPV) testing after atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion (ASC-US/LSIL) screening results. In the Netherlands, ASC-US/LSIL is triaged by repeat cytology at 6 months or repeat cytology at 6 months with additional hrHPV testing. ASC-US/LSIL results from 13,734 screenees in 2008 were extracted from “Dutch Pathology Registry” including cytology, histology, and/or HPV follow-up results. Proportions of compliance, repeat cytology, referral, and detected cervical intraepithelial neoplasia (CIN) were assessed. With additional hrHPV testing, 46.8 % was send back to regular screening at 6 months, 28.6 % needed second repeat cytology, and 24.6 % was referred for colposcopy. Without additional hrHPV testing, this was 0.0, 76.1, and 23.9 %, respectively. With additional hrHPV testing, significantly higher proportions of persisting ASC-US/LSIL; compliance with repeat/referral advices; and histological detection of CIN0 (no CIN or cancer), CIN1, and CIN2 were found but equal proportions CIN3+. Additional hrHPV testing shortens follow-up without altering CIN3+ detection. Detection of CIN0, CIN1, and CIN2 was higher, presumably by hrHPV-driven biased cytology and detection bias. Restricting additional hrHPV testing to older women, reading cytology without knowledge of hrHPV status, and addition of more specific triage tests could further improve the effectiveness of additional hrHPV testing.
- 3 June 2014
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 160 (11) , 750-759
Should Colorectal Cancer Screening Be Considered in Elderly Persons Without Previous Screening?
Some guidelines caution against routine screening for colorectal cancer in persons older than 75 years with an adequate screening history but have not addressed screening in those without a screeni... Background: The U.S. Preventive Services Task Force recommends against routine screening for colorectal cancer (CRC) in adequately screened persons older than 75 years but does not address the appr...
- 3 June 2014
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 160 (11) , 750-759
Should Colorectal Cancer Screening Be Considered in Elderly Persons Without Previous Screening?
Some guidelines caution against routine screening for colorectal cancer in persons older than 75 years with an adequate screening history but have not addressed screening in those without a screeni... Background: The U.S. Preventive Services Task Force recommends against routine screening for colorectal cancer (CRC) in adequately screened persons older than 75 years but does not address the appr...
- Open Access
- 15 May 2014
- Published by Springer Nature in BMC Public Health
- Vol. 14 (1) , 454
Parents’ preferences for vaccinating daughters against human papillomavirus in the Netherlands: a discrete choice experiment
To generate knowledge about potential improvements to human papillomavirus (HPV) vaccination information and organization strategies, we assessed how aspects of HPV vaccination are associated with parents’ preferences for their daughters’ uptake, and which trade-offs parents are willing to make between these aspects.
- 15 May 2014
- Published by Springer Nature in BMC Public Health
- Vol. 14 (1) , 454
Open AccessParents’ preferences for vaccinating daughters against human papillomavirus in the Netherlands: a discrete choice experiment
To generate knowledge about potential improvements to human papillomavirus (HPV) vaccination information and organization strategies, we assessed how aspects of HPV vaccination are associated with parents’ preferences for their daughters’ uptake, and which trade-offs parents are willing to make between these aspects.
- Open Access
- 26 June 2013
- Published by Springer Nature in BMC Public Health
- Vol. 13 (1) , 611
Increasing girls’ knowledge about human papillomavirus vaccination with a pre-test and a national leaflet: a quasi-experimental study
Adolescent girls are at an age to be involved in the decision about HPV vaccination uptake and therefore need adequate information about the vaccination. This study assesses to what extent reading an official information leaflet about HPV contributes to girls’ knowledge levels, and to what extent an increase in knowledge is boosted by a pre-test measurement. Participants (girls aged 11–14 years) were systematically allocated to group A that completed a pre-test measurement (12 true/false statements) or to group B that did not complete it. Subsequently, both groups read the HPV leaflet and completed the post-test measurement. The response rate was 237/287 (83%). Pre-test scores in group A (M = 3.6, SD = 1.81, p < 0.001) were lower than post-test mean knowledge scores (0–10) in group B (M = 4.6, SD = 2.05). Post-test knowledge scores in group A were higher than those in group B [6.2 (SD = 2.06) versus 4.6 (SD = 2.05), p < 0.001]. In the post-test measurement, about a third of both groups knew that vaccinations do not give 100% protection against cervical cancer and that the duration of protection is unknown. Reading the information leaflet had a positive effect on knowledge, even more so when boosted by a pre-test measurement. However, knowledge on the degree and duration of protection against cervical cancer remained limited. Focusing girls’ attention on important aspects before they start reading the leaflet (e.g. by including a quiz on the first page) may serve to raise their awareness of these aspects.
- 26 June 2013
- Published by Springer Nature in BMC Public Health
- Vol. 13 (1) , 611
Open AccessIncreasing girls’ knowledge about human papillomavirus vaccination with a pre-test and a national leaflet: a quasi-experimental study
Adolescent girls are at an age to be involved in the decision about HPV vaccination uptake and therefore need adequate information about the vaccination. This study assesses to what extent reading an official information leaflet about HPV contributes to girls’ knowledge levels, and to what extent an increase in knowledge is boosted by a pre-test measurement. Participants (girls aged 11–14 years) were systematically allocated to group A that completed a pre-test measurement (12 true/false statements) or to group B that did not complete it. Subsequently, both groups read the HPV leaflet and completed the post-test measurement. The response rate was 237/287 (83%). Pre-test scores in group A (M = 3.6, SD = 1.81, p < 0.001) were lower than post-test mean knowledge scores (0–10) in group B (M = 4.6, SD = 2.05). Post-test knowledge scores in group A were higher than those in group B [6.2 (SD = 2.06) versus 4.6 (SD = 2.05), p < 0.001]. In the post-test measurement, about a third of both groups knew that vaccinations do not give 100% protection against cervical cancer and that the duration of protection is unknown. Reading the information leaflet had a positive effect on knowledge, even more so when boosted by a pre-test measurement. However, knowledge on the degree and duration of protection against cervical cancer remained limited. Focusing girls’ attention on important aspects before they start reading the leaflet (e.g. by including a quiz on the first page) may serve to raise their awareness of these aspects.
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
9 Physician Adenoma Detection Rate Variability and Subsequent Colorectal Cancer Risk Following a Negative Colonoscopy
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
9 Physician Adenoma Detection Rate Variability and Subsequent Colorectal Cancer Risk Following a Negative Colonoscopy
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
1023 Impact of Variation in Screening Colonoscopy Quality on the Prevention of Colorectal Cancer Deaths. A Modelling Study
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
1023 Impact of Variation in Screening Colonoscopy Quality on the Prevention of Colorectal Cancer Deaths. A Modelling Study
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
351 Adherence to Screening in a Randomized Controlled Trial of a One-Time Screening Colonoscopy Versus Program of Annual Fecal Occult Blood Test (gFOBt): Implications of Lower gFOBt Adherence to Screening on Colorectal Cancer Mortality Reduction
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
351 Adherence to Screening in a Randomized Controlled Trial of a One-Time Screening Colonoscopy Versus Program of Annual Fecal Occult Blood Test (gFOBt): Implications of Lower gFOBt Adherence to Screening on Colorectal Cancer Mortality Reduction